WHO ICTRP trial
A Phase I/II Study of RO4893594-PDS in Japanese Patients with Neovascular…
JPRN-jRCT2071210073 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2071210073 |
|---|---|
| Public title | A Phase I/II Study of RO4893594-PDS in Japanese Patients with Neovascular Age-Related Macular Degeneration and Japanese Patients with Diabetic Macular Edema |
| Scientific title | A Phase I/II Study of RO4893594-PDS in Japanese Patients with Neovascular Age-Related Macular Degeneration and Japanese Patients with Diabetic Macular Edema |
| Primary sponsor | Ogura Yuichiro |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 1-2 |
| Conditions | Neovascular age-related macular degeneration (nAMD) and with diabetic macular edema (DME) |
| Interventions | Ranibizumab: After surgical insertion of an implant filled with ranibizumab filling solution into the study eye using an implant tool, the ranibizumab filling solution will be refilled directly into the implant inserted into the eye at… |
| Registration date | Feb 10, 2021 |
| Target size | 21 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: